The National Acquisition Center, a civilian agency of the U.S. government, has awarded a single-award Blanket Purchase Agreement (BPA) to Chiesi USA Inc., a foreign-owned for-profit organization, to supply the Department of Veterans Affairs with the pharmaceutical products Ferriprox and Revcovi. The $2,250,000 BPA, established under Chiesi's Federal Supply Schedule 61 contract for Pharmaceuticals and Drugs, has an ultimate completion date of September 9, 2025.
In addition to the BPA, Chiesi USA Inc. holds an Indefinite Delivery/Indefinite Quantity (ID/IQ) Federal Supply Schedule contract valued at up to $27.7 million, under which the VA has issued delivery orders for deferiprone tablets in support of its medical programs. This contract mechanism allows the VA to efficiently acquire critical pharmaceutical products from Chiesi to address the healthcare needs of veterans.
Generated 12/22/24, 12:02 AM